Associate Professor, Pathology, University of Washington School of Medicine

Pathology

Dr. Min Fang, MD

Fang works in the field of Pathology. Fang is also published. She has 14 publications published. The lastest publication: "Acquisition of a CD19 negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T cell therapy.'

Publications

Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence.
Acquisition of a CD19 negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T cell therapy.
Reevaluation of the Pretransplant Assessment of Mortality Score after Allogeneic Hematopoietic Transplantation.
Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia.
Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute ...
Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia.
Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification.
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.
The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnos...
A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.
Chronic myelogenous leukemia presenting in blast crisis with nodal, bilineal myeloid sarcoma and T-lymphoblastic lymphoma in a child.
Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities.
A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate ...

Doctors Specialties

Cytopathology
Pathology

Accepted Insurances

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Peter M. Benda, MD This Doctor is OpenDoctor Recommended.
	Dr. Peter E. Bertozzi Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Semra Olgac, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. James P. Aubuchon, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Marla R. Fenske, MD This Doctor is OpenDoctor Recommended.
	Dr. David J. Glidden, MD This Doctor is OpenDoctor Recommended.
	Dr. Anne M. Leavitt, MD
	Dr. Sindhu Cherian, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven C. Quay, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Atis Muehlenbachs, MD This Doctor is OpenDoctor Recommended.
	Dr. Bruce G. Kulander, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Richard G. Patton, MD This Doctor is OpenDoctor Recommended.
	Dr. Malcolm S. Stirton, MD This Doctor is OpenDoctor Recommended.
	Dr. Emily H. Glynn, MD This Doctor is OpenDoctor Recommended.
	Dr. Sandra L. White, MD This Doctor is OpenDoctor Recommended.